Control ADHD Symptoms With Vyvanse
Links shared publicly online about this topic
Study Demonstrated Once-Daily Vyvanse(R) CII Provided Significant Improvement Of ADHD Symptoms For Children At 13 Hours After Administration
medicalnewstoday.com — “Shire plc announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse® (lisdexamfetamine dimesy” View full resource at medicalnewstoday.com
Most Recently Shared on August 2, 2009 at 10:37 am By:
Study Demonstrated Once-Daily Vyvanse(R) CII Provided Significant Improvement Of ADHD Symptoms For Children At 1.. http://bit.ly/xYvdk
Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules
medicalnewstoday.com — “Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse&r” View full resource at medicalnewstoday.com
Most Recently Shared on November 13, 2009 at 1:10 pm By:
Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (l.. http://bit.ly/36XeTm
Vyvanse approved for pediatric ADHD control 13 hours post-dose - MPR
empr.com — “Shire Pharmaceuticals has received FDA approval for a labeling change for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment Vyvanse (lisdexamfetamine dimesylate capsules).” View full resource at empr.com
Most Recently Shared on June 1, 2009 at 6:07 pm By:
MPR News: Vyvanse approved for pediatric ADHD control 13 hours post-dose: Shire Pharmaceuticals has rec.. http://tinyurl.com/njqgk4
Study Demonstrated Once-Daily Vyvanse(R) CII Provided Significant Improvement Of ADHD Symptoms For Children At 13 Hours After Administration | Psydir News
news.psydir.com — “Shire plc announced that a study published online in the peer-reviewed journal Child and Adolescent Psychiatry and Mental Health found once-daily Vyvanse (lisdexamfetamine dimesylate) CII significantly reduced the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 from the first time point measured (1.5 hours) up to the last time point assessed (13 hours) afte...” View full resource at news.psydir.com
Most Recently Shared on August 2, 2009 at 12:31 pm By:
Study Demonstrated Once-Daily Vyvanse(R) CII Provided Significant Improvement Of ADHD Symptoms For Children At 13 H... http://ow.ly/15JA1x
FDA Approves Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents
drugs.com — “Vyvanse (lisdexamfetamine) is used to treat ADHD. Includes Vyvanse side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 15, 2010 at 10:57 pm By:
FDA Approves Vyvanse (lisdexamfetamine dimesylate) for the Treatment of ADHD in Adolescents - http://bit.ly/9kNj6A
FDA Approves Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents
drugs.com — “Vyvanse (lisdexamfetamine) is used to treat ADHD. Includes Vyvanse side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 15, 2010 at 11:03 pm By:
FDA Approves Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents: ... http://bit.ly/c1yPph #drug
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse&r” View full resource at medicalnewstoday.com
Most Recently Shared on November 14, 2009 at 12:57 pm By:
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse: Shire plc (LSE: SHP, .. http://bit.ly/L7ol7
Neurotransmitters Involved in ADHD | Psych Central
psychcentral.com — “Attention deficit hyperactivity disorder (ADHD) causes symptoms that can disrupt a patient's life. For example, the patient can have problems sustaining” View full resource at psychcentral.com
Most Recently Shared on May 11, 2010 at 7:31 pm By:
New Article: Neurotransmitters Involved in ADHD http://bit.ly/9uuQcr
Study Evaluated Vyvanse (lisdexamfetamine dimesylate) Capsules CII Efficacy and Safety in Adolescents with ADHD - Drugs.com MedNews
drugs.com — “Data Showed Vyvanse Significantly Improved ADHD Symptoms of Inattention, Hyperactivity and Impulsivity in Adolescents Aged 13 to 17 Shire plc , the global speci” View full resource at drugs.com
Most Recently Shared on May 26, 2010 at 5:19 pm By:
Study Evaluated Vyvanse (lisdexamfetamine dimesylate) Capsules CII Efficacy and Safety in Adolescents with AD... http://bit.ly/dDjjni #adhd
NIMH · Attention Deficit Hyperactivity Disorder (ADHD)
nimh.nih.gov — “A detailed booklet that describes ADHD symptoms, causes, and treatments, with information on getting help and coping.” View full resource at nimh.nih.gov
Most Recently Shared on September 12, 2009 at 12:10 am By:
Study found the brain chemistry of ADHD patients lack a particular protein http://ow.ly/p1wY More on ADHD http://ow.ly/p1x8
Relationships and ADHD: Obstacles and Solutions | Psych Central
psychcentral.com — “Although people with attention deficit hyperactivity disorder (ADHD) can be very successful in life, the symptoms of adult ADHD can put a real strain on” View full resource at psychcentral.com
Most Recently Shared on April 6, 2010 at 7:54 pm By:
New Article: Relationships and ADHD: Obstacles and Solutions http://bit.ly/b8Ofej
ADHD Support: Vyvanse (lisdexamfetamine dimesylate) Cll Patient Assistance Program
vyvanseadult.com — “Vyvanse (lisdexamfetamine dimesylate) Cll Patient Assistance Program provides helpful information and support to patients having trouble affording Vyvanse (lisdexamfetamine dimesylate) Cll medication. See Important Safety Information.” View full resource at vyvanseadult.com
Most Recently Shared on April 16, 2010 at 10:45 pm By:
Patient assistance programs help adults and children with ADHD more easily afford Vyvanse to control their symptoms. http://bit.ly/a4rpL3
Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents
news-medical.net — “Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD. Vyvanse is also indicated for the treatment of ADHD i” View full resource at news-medical.net
Most Recently Shared on November 15, 2010 at 3:49 pm By:
Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents: Shire plc, the global specialty bi... http://bit.ly/a0SfMQ
Vyvanse (lisdexamfetamine dimesylate) CII ADHD Medication for Kids. Read full Important Safety Information.
vyvansekids.com — “Vyvanse (lisdexamfetamine dimesylate): ADHD symptom control medication for children age 6 and 12. See the Important Safety Information. See Full Prescribing Information and Medication Guide.” View full resource at vyvansekids.com
Most Recently Shared on November 19, 2009 at 12:48 am By:
Dealing with ADHD in children is a 24-hour issue, and their medication should be, too. Learn about Vyvanse. http://bit.ly/cpRDHg
9 Time Management Tips for Adult ADHD - ADD/ADHD Center - Everyday Health
everydayhealth.com — “Time management and completing tasks is a real challenge for people with adult ADHD. Learn these time-management skills to gain control of your ADHD symptoms.” View full resource at everydayhealth.com
Most Recently Shared on March 23, 2012 at 11:50 pm By:
Create daily to-do lists! More time management tips for adults with ADHD: http://t.co/qNAMuHZ5
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
psychiatryrounds
Professional social network for psychiatrists to discuss, share insights, collaborate, and network!
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement

